You are here

MARKER GENE TECHNOLOGIES INC

Company Information
Address
1850 MILLRACE DR STE 4
EUGENE, OR 97403-2095
United States



Information

UEI: LDL9MLRAHY77

# of Employees: 8


Ownership Information

HUBZone Owned: Yes

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Live-Cell Assays of ER and Golgi Enzyme Activities

    Amount: $1,097,123.00

    RESEARCH STRATEGY PROJECT SUMMARY ABSTRACTThis Administrative Supplement to our Small Business Innovation Research Phase II project will take advantage of new advances in liquid handling instrumentati ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  2. Targeted Pharmacological Chaperones for Neurological Diseases

    Amount: $224,593.00

    DESCRIPTION provided by applicant This Small Business Innovation Research Phase I project aims to develop new targeted pharmacological chaperones capable of modulating enzyme degradation in the Gol ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  3. Promoting School Readiness and Successful Transitions through Parent Training

    Amount: $149,757.00

    DESCRIPTION: This Small Business Innovation Research Phase I project aims to develop new targeted fluorogenic substrates capable of measuring enzyme activities in the Golgi apparatus and Endoplasmic R ...

    SBIRPhase I2013Department of Health and Human Services National Institutes of Health
  4. Live-Cell Assays for Lysosomal Enzyme Activity

    Amount: $1,533,541.00

    DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase II project aims to develop new targeted fluorogenic substrates capable of measuring lysosomal enzyme activity in livi ...

    SBIRPhase II2012Department of Health and Human Services National Institutes of Health
  5. SBIR Phase II: New Labeling Reagents for Genetic Analysis

    Amount: $499,889.00

    This Small Business Innovation Research Phase II project aims to develop new, sensitive, accurate, and reliable detection methods for measuring genomic DNA or RNA samples isolated from living cells. T ...

    SBIRPhase II2009National Science Foundation
  6. SBIR Phase I: New Labeling Reagents for Genetic Analysis

    Amount: $99,959.00

    This Small Business Innovation Research (SBIR) Phase I research project aims to develop novel nucleic acid labeling reagents that can be used in living cells to monitor gene expression. Instead of re ...

    SBIRPhase I2008National Science Foundation
  7. Live-Cells Assays for Lysosomal Enzyme Activity

    Amount: $199,822.00

    DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project aims to develop new targeted fluorogenic substrates capable of measuring lysosomal enzyme activity in livin ...

    SBIRPhase I2007Department of Health and Human Services National Institutes of Health
  8. POSITIVE SELECTION SYSTEMS USING MARKER GENES

    Amount: $99,879.00

    This Small Business Innovation Research Phase I project aims to investigate the feasibility of developing new compounds capable of utilizing common marker gene expression in transformed cells to contr ...

    SBIRPhase I2005Department of Health and Human Services National Institutes of Health
  9. SBIR/STTR Phase I: New GUS Substrates for Cell Regulation

    Amount: $99,972.00

    This Small Business Innovation Research (SBIR) Phase I project is to develop commercial uses for conjugates capable of exploiting cloned gene expression in transformed plant cells to control their gro ...

    SBIRPhase I2002National Science Foundation
  10. NEW LABELING REAGENTS FOR GENETIC ANALYSIS

    Amount: $99,982.00

    DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project aims to investigate the feasibility of developing new, sensitive, accurate, and reliable detection methods ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government